Chris Juttner

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The encouraging pace of discovery and development in the field of regenerative medicine holds tremendous potential for bringing therapies to the clinic that may offer meaningful benefit to patients, particularly in diseases with no or suboptimal therapeutic options. Academic researchers will continue to play a critical role in developing concepts and(More)
Administration of donor T cells expressing the herpes simplex–thymidine kinase (HS-tk) with a hematopoietic stem cell (HSC) transplantation could allow, if graftversus-host disease (GVHD) was to occur, a selective in vivo depletion of these T cells by the use of ganciclovir (GCV). The study evaluates the feasibility of such an approach. Escalating numbers(More)
  • 1